# Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer

> **NCT05878405** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 49 (actual)

## Conditions studied

- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Stomatitis

## Interventions

- **OTHER:** Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse
- **OTHER:** Methylene Blue Oral Rinse

## Key facts

- **NCT ID:** NCT05878405
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-06
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05878405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05878405, "Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT05878405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*